E.coli-derived human UFM1 recombinant protein (Position: M1-C85). Human UFM1 shares 100% and 98.8% amino acid (aa) sequence identity with mouse and rat UFM1, respectively.
Each vial contains 50% glycerol, 0.9% NaCl, 0.2% Na2HPO4.
Purity:
Immunogen affinity purified.
Form:
Liquid
Target:
Ubiquitin-fold modifier 1
Application Dilute:
Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
* VAT and and shipping costs not included. Errors and price changes excepted